{"id":1167,"slug":"干细胞丰胸-干细胞脂肪填充是不是智商税-svf到底是什么东西","question":"干细胞丰胸、干细胞脂肪填充是不是智商税？SVF到底是什么东西？","intent":"informational","language":"zh","url":"https://worldwiki.io/q/干细胞丰胸-干细胞脂肪填充是不是智商税-svf到底是什么东西","entity":{"slug":"svf-assisted-fat-grafting","name":"SVF-assisted Fat Grafting","url":"https://worldwiki.io/entity/svf-assisted-fat-grafting"},"answer":{"short_answer":"广告里的“干细胞丰胸”多数指的是SVF辅助脂肪移植（CAL）：抽脂后把一部分脂肪现场处理成基质血管成分，再与剩余脂肪混合注射 [3]。它用的是新鲜分离的混合细胞群，不是体外培养扩增的干细胞治疗，两者在概念和监管上都不一样 [8]。它不是骗局，但也不是已被高质量证据确立的常规做法——现有研究汇总结果偏正面，质量却普遍偏弱 [4][7]。","detailed_answer":"<p>最早的临床描述见于Yoshimura K等人2008年的隆胸研究：约一半抽出的脂肪被处理成新鲜SVF，再与另一半脂肪重新混合注射，脂肪本身作为活的支架 [3]。</p><p>需要分清三件事：一是SVF这种术中分离的混合细胞群；二是体外培养扩增的干细胞治疗；三是商家用“干细胞”作为营销标签的各类项目。本条目的来源只覆盖第一类。国际干细胞研究学会（ISSCR）发布有关于干细胞研究与临床转化的指南，可作为判断相关宣传的参考框架 [11]。</p><p>如果咨询时对方无法说明细胞是怎么分离的、注射了多少、用什么方法测量效果，这些宣传就无法核查。</p>","format":"paragraph","confidence":75,"verified_at":null,"updated_at":"2026-09-20 17:11:10"},"sources":[{"id":152,"title":"Cell-Assisted Lipotransfer for Cosmetic Breast Augmentation: Supportive Use of Adipose-Derived Stem/Stromal Cells, Yoshimura K et al.","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2175019/","publisher":"Aesthetic Plastic Surgery","type":"journal","accessed_at":"2026-09-18 18:01:10"},{"id":255,"title":"Clinical Efficacy of Adipose-Derived Stem Cell-Enriched Lipotransfer Versus Conventional Fat Grafting: A Systematic Review and Meta-Analysis","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13090857/","publisher":"Cureus, via PubMed Central","type":"journal","accessed_at":"2026-09-19 18:00:25"},{"id":279,"title":"Cell-Assisted Lipotransfer: A Systematic Review of Its Efficacy","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4819466/","publisher":"Aesthetic Plastic Surgery (Springer) via PubMed Central","type":"journal","accessed_at":"2026-09-19 18:00:41"},{"id":242,"title":"Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use","url":"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal","publisher":"U.S. Food and Drug Administration","type":"government","accessed_at":"2026-09-19 18:00:14"},{"id":14,"title":"ISSCR Guidelines for Stem Cell Research and Clinical Translation","url":"https://www.isscr.org/guidelines","publisher":"International Society for Stem Cell Research","type":"organization","accessed_at":"2026-09-19 18:01:07"}],"published_at":"2026-09-20 08:11:10"}